Citation 82857

IORIZZI,M: BRYAN,P: MC CLINTOCK,J: MINALE,L: PALAGIANO,E: MAURELLI,S: RICCIO,R: ZOLLO,F:. (1995). CHEMICAL AND BIOLOGICAL INVESTIGATION OF THE POLAR CONSTITUENTS OF THE STARFISH LUIDIA CLATHRATA, COLLECTED IN THE GULF OF MEXICO.. 58(5)

Citation Details

TitleCHEMICAL AND BIOLOGICAL INVESTIGATION OF THE POLAR CONSTITUENTS OF THE STARFISH LUIDIA CLATHRATA, COLLECTED IN THE GULF OF MEXICO.
AuthorsIORIZZI,M: BRYAN,P: MC CLINTOCK,J: MINALE,L: PALAGIANO,E: MAURELLI,S: RICCIO,R: ZOLLO,F:
Year1995
Volume58
Issue5

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (1)

Luidia clathrata (LUIDIIDAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHOLESTANE,5-ALPHA: 3-BETA-5-6-BETA-15-ALPHA-16-BETA-PENTAOL-16-SULFATE:
None
2
FEEDING DETERRENT(FISH)
PHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE
3
ANTIFOULING ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE
4
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE
5
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF EXTRACT - IN VITRO
None
ACTIVE
6
ANTIFOULING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CHOLESTANE,5-ALPHA: 3-BETA-5-6-BETA-15-ALPHA-16-BETA-PENTAOL-16-SULFATE:CHOLESTANE,5-ALPHA: 3-BETA-5-6-BETA-15-ALPHA-16-BETA-26-HEXAOL-26-SULFATE: 25(S):CHOLESTA-3-BETA-5-6-BETA-15-ALPHA-16-BETA-26-HEXAOL-26-SULFATE,24-METHYL-5-ALPHA: (24R-25S):CHOLESTANE-3-BETA-5-6-BETA-15-ALPHA-29-PENTAOL-29-SULFATE,24-ETHYL-5-ALPHA: 24(R):CHOLESTA-TRANS-22-EN-3-BETA-5-6-BETA-15-ALPHA-28-PENTAOL-28-SULFATE,24-METHYL-5-ALPHA: 24(S):CHOLESTA-3-BETA-5-6-BETA-15-ALPHA-24-28-HEXAOL-28-SULFATE,24-METHYL-5-ALPHA: 24(R):CHOLESTANE,5-ALPHA: 3-BETA-6-BETA-15-ALPHA-16-BETA-26-PENTAOL: 25(S):
ACTIVE
7Not specified
STEREOCHEMISTRY DETERMINED FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHLOSTANE,5-BETA: 3-BETA-6-BETA-15-ALPHA-16-BETA-TETRAOL: 25(S):
None
8
ANTIFOULING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CHLOSTANE,5-BETA: 3-BETA-6-BETA-15-ALPHA-16-BETA-TETRAOL: 25(S):
ACTIVE
9Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHOLESTANE,5-ALPHA: 3-BETA-5-6-BETA-15-ALPHA-16-BETA-26-HEXAOL-16-SULFATE: 24(S):
None
10
ANTIFOULING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CHOLESTANE,5-ALPHA: 3-BETA-5-6-BETA-15-ALPHA-16-BETA-26-HEXAOL-16-SULFATE: 24(S):
ACTIVE
11Not specified
ABSOLUTE CONFIGURATION DETERMINEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHOLESTA-TRANS-22-EN-3-BETA-5-6-BETA-15-ALPHA-26-PENTAOL-26-SULFATE,24-METHYL-5-ALPHA: (24R-25S):
None
12
ANTIFOULING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CHOLESTA-TRANS-22-EN-3-BETA-5-6-BETA-15-ALPHA-26-PENTAOL-26-SULFATE,24-METHYL-5-ALPHA: (24R-25S):
ACTIVE
13Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHOLESTANE-3-BETA-5-6-BETA-15-ALPHA-24-PENTAOL-15-SULFATE,5-ALPHA: 24(S):
None
14
ANTIFOULING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CHOLESTANE-3-BETA-5-6-BETA-15-ALPHA-24-PENTAOL-15-SULFATE,5-ALPHA: 24(S):
ACTIVE
15Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
CHOLESTANE,5-ALPHA: 3-BETA-5-6-BETA-15-ALPHA-16-BETA-26-HEXAOL: 25(S):
None
16
ANTIFOULING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CHOLESTANE,5-ALPHA: 3-BETA-5-6-BETA-15-ALPHA-16-BETA-26-HEXAOL: 25(S):
ACTIVE
17Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
CHOLESTANE,5-ALPHA: 3-BETA-6-BETA-7-ALPHA-15-ALPHA-16-BETA-26-HEXAOL: 25(S):
None
18
ANTIFOULING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
CHOLESTANE,5-ALPHA: 3-BETA-6-BETA-7-ALPHA-15-ALPHA-16-BETA-26-HEXAOL: 25(S):
ACTIVE
19Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
THORNASTEROSIDE A
None
20
ANTIFOULING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
THORNASTEROSIDE A
ACTIVE
21Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
OPHIDIANOSIDE F
None
22
ANTIFOULING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
OPHIDIANOSIDE F
ACTIVE
23Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
REGULAROSIDE B
None
24
ANTIFOULING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
REGULAROSIDE B
ACTIVE
25Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
MARTHASTEROSIDE B
None
26
ANTIFOULING ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITRO
MARTHASTEROSIDE B
ACTIVE
27Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHOLESTANE,5-ALPHA: 3-BETA-5-6-BETA-15-ALPHA-16-BETA-26-HEXAOL-26-SULFATE: 25(S):
None
28Not specified
ABSOLUTE CONFIGURATION DETERMINEDMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHOLESTA-3-BETA-5-6-BETA-15-ALPHA-16-BETA-26-HEXAOL-26-SULFATE,24-METHYL-5-ALPHA: (24R-25S):
None
29Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHOLESTANE-3-BETA-5-6-BETA-15-ALPHA-29-PENTAOL-29-SULFATE,24-ETHYL-5-ALPHA: 24(R):
None
30Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHOLESTA-TRANS-22-EN-3-BETA-5-6-BETA-15-ALPHA-28-PENTAOL-28-SULFATE,24-METHYL-5-ALPHA: 24(S):
None
31Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CHOLESTA-3-BETA-5-6-BETA-15-ALPHA-24-28-HEXAOL-28-SULFATE,24-METHYL-5-ALPHA: 24(R):
None
32Not specified
ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA
CHOLESTANE,5-ALPHA: 3-BETA-6-BETA-15-ALPHA-16-BETA-26-PENTAOL: 25(S):
None
Show SPARQL Queries (1)